No Data
Winox Supplements 2012–2014 Reports With Former CEO Pay Details
WINOX: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORTS FOR THE YEARS ENDED 31 DECEMBER 2012, 31 DECEMBER 2013 AND 31 DECEMBER 2014
Winox Flags Sharply Wider 2025 Loss on Weak Demand and Restructuring Costs
Profit Time (06838.HK): Recorded a loss of approximately HKD 54 million for the 11 months ended November 30.
Gelonghui, January 8th: Yingli Shi (06838.HK) announced that the group recorded a loss of approximately HKD 54 million for the eleven months ended November 30, 2025 (Full year 2024: loss of HKD 20.329 million). The loss was primarily attributable to (1) a decrease in revenue of about 20% compared to the same period last year due to weak demand; (2) a decline in overall gross margin as a result of intense market competition; and (3) severance compensation of approximately HKD 12 million paid under the workforce streamlining plan.
Formosa Pharmaceuticals Gets Nod to Register Eye Pain Relief Drug in South Africa
Formosa Pharmaceuticals Grants Commercialization Rights for Post-Op Pain Relief Drug